Recent Molecular Trends and Prospects in Kidney Diseases

Dear Colleagues,

Recent advances in molecular research have illuminated novel insights into the pathogenesis of and potential treatments for kidney diseases. Molecular trends indicate a shift toward a deeper understanding of the genetic factors contributing to kidney disorders, such as the identification of genetic variants associated with kidney function and disease susceptibility. Genome-wide association studies (GWAS) have been instrumental in pinpointing these genetic loci, paving the way for personalized medicine approaches.

Furthermore, research has elucidated the intricate molecular pathways involved in kidney injury and repair, shedding light on potential therapeutic targets. For instance, investigations into the role of inflammatory cytokines, oxidative stress and fibrosis have provided valuable insights into the mechanisms underlying chronic kidney disease (CKD) progression. Targeting these pathways holds promise for developing more effective treatments to halt or reverse kidney damage.

Additionally, advancements in molecular diagnostics, including the use of biomarkers and omics technologies, offer new tools for the early detection, prognosis and monitoring of kidney diseases. These approaches enable clinicians to tailor interventions to individual patients, improving outcomes and reducing the burden of kidney-related morbidity and mortality.

Overall, recent molecular trends in kidney disease research underscore the importance of a multifaceted approach, integrating genetics, molecular biology and clinical medicine to drive innovation in diagnosis and treatment strategies. While challenges remain, ongoing research efforts hold considerable promise for improving the management of kidney diseases in the future.

Dr. Federico Greco
Dr. Carlo A. Mallio
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• nephrology
• molecular biology
• renal disease
• genomic research
• kidney molecular pathways
• biomarkers in renal disease
• transcriptomics of renal dysfunction
• omics approaches in kidney research
• molecular diagnostics for renal diseases
• pharmacogenomics in kidney treatment